BTG dropped thru' the floor on Friday due to the U.S. regulators suspending a clinical trial of its biggest new drug hope, an treatment for varicose veins...
Shares went from 380p to 154p in half an hour.
Wasn't 2 weeks ago that Investors Chronicle was predicting 700p & a 'STRONG BUY'(based on this new vaicose vein treatment launch, of course)..

Just wondering....at 154p, is it a good time to get in? I've got no idea how the US regulators work, but 'suspending' a trial doesn't sound too final to me!
Any opinions would be appreciated

BTG PLC
14 November 2003



14 November 2003 - for immediate release



BTG plc: Statement on Varisolve(R) US Phase II safety study



BTG plc (LSE: BGC), the global technology commercialisation company, today
announced that it has been informed verbally by the US Food & Drug
Administration (FDA) of a decision to place on clinical hold a Phase II safety
study of Varisolve(R), a new treatment for varicose veins being developed by
Provensis, BTG's subsidiary.



FDA has indicated it will write to Provensis describing the reasons for placing
the study on clinical hold. BTG will make a further announcement after
receiving the FDA's letter and assessing the impact on the further clinical
development of Varisolve(R).



Ends



For further information contact:


BTG
Andy Burrows, Director of Investor Relations
+44 (0)20 7575 1741
07990 530605




This information is provided by RNS
The company news service from the London Stock Exchange

I have been informed that there are concerns about accidental injecting into arteries.

up 21% today... lucky I took a chance!

VAS, well done you called it right. I stayed out and am cursing myself now.

cheers GF.

covered +17 :-)